Biomarkers in Neuroimaging

Neuroimaging has helped to elucidate that substance-use disorders are associated with changes in brain structure, function, and neurochemistry. Neuroimaging studies have improved our understanding of the neural correlates of addiction and how these relate to addictive behavior. Nevertheless, the potential impact of neuroimaging on treatment development for addictions has yet to be fully realized. Despite substantial advances, treatments are often not fully effective, and addiction continues to be a major public health burden . Neuroimaging has contributed to our appreciation of the complexity of addiction, highlighting the need for measurable indices, or biomarkers, of addiction to improve treatment outcomes. A “biomarker” typically refers to a measurable indicator of normal or abnormal biological processes or response to treatment . In substance-abuse research, biomarkers are needed to clarify how or why a treatment has an effect, on whom and under what circumstances.

Recent advances in neuroimaging are affording greater opportunities to identify brain biomarkers that might be used to improve outcomes of treatment for substance-use disorders. Neuroimaging is a critical tool in biomarker development because it relates neural circuits to both molecular mechanisms and behavior or clinical variation. In particular, neuroimaging studies are central to an emerging research effort to identify cross-diagnostic processes in substance-use and related disorders based on both behavior and neural circuits . In this work, alterations in brain activation patterns related to dimensions of functioning in individuals with addictions may be considered to represent abnormal processing associated with addictive behavior. Such research holds significant potential for identifying targets for treatment, detecting subgroups for treatment selection, and/or predicting treatment response . As disorder heterogeneity and individual variation pose significant challenges for delivering effective treatment, considering addictions in terms of dimensions of functioning may help to elucidate factors relevant to treatment response and lead to more specific, more effective treatments . This paper reviews neuroimaging research seeking to identify potential biomarkers of treatment response from several dimensions of functioning relevant to addiction:, impulsivity, and cognitive control.


    Related Conference of Biomarkers in Neuroimaging

    August 18-19, 2022

    16th World Congress on Hematology and Oncology

    Tokyo, Japan
    August 25-26, 2022

    10th World Congress on Depression and Anxiety

    Las Vegas, USA
    August 29-30, 2022

    13th Global Alzheimers Summit

    Copenhagen, Denmark
    September 05-06, 2022

    World Neuroscience Summit

    Dublin, Ireland
    September 16-17, 2022

    International Conference on Neurology & Neuro Science

    Berlin, Germany
    September 26-27, 2022

    28th World Congress on Neurology and Neurodisorders

    Rome, Italy
    September 27-28, 2022

    World Congress on Neurosurgery and Neuroscience

    Berlin, Germany
    October 10-11, 2022

    28th Global Experts Meeting on Neuropharmacology

    Vienna, Austria
    October 24-25, 2022

    5th World Neuron Congress

    Paris, France
    October 24-25, 2022

    31st Euro Congress on Neurologists and Psychiatrists

    Paris, France
    November 10-11, 2022

    4th World Depression Congress

    Madrid, Spain
    November 14-15, 2022

    5th International Conference on Neurology and Psychology

    Amsterdam, Netherlands
    November 14-15, 2022

    3rd World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    November 21-22, 2022

    14th Global Summit on Neuroscience & Neurological Disorders

    Budapest, Hungary
    December 05-06, 2022

    3rd World Congress on Neurology and Neuropsychiatry

    Rome, Italy
    December 08-09, 2022

    7th World Congress on Spine and Spinal Disorders

    Tokyo, Japan
    December 19-20, 2022

    4th Global Summit on Neurology

    Zurich, Switzerland
    January 23-24, 2023

    15th World Congress on Pediatric Medicine and Neonatology

    Rome, Aland Islands
    January 25-26, 2023

    32nd world congress on Neurology and Therapeutics

    Barcelona, Spain
    February 15-16, 2023

    3rd Global Summit on Brain Disorders and Therapeutics

    Zurich, Switzerland
    February 16-17, 2023

    World Congress on Stress and Anxiety

    London, UK
    February 20-21, 2023

    15th International Conference on Vascular Dementia

    Paris, France
    February 27-28, 2023

    International Conference on Alzheimer and Dementia

    London, UK
    April 18-19, 2023

    4th International Conference on Neurologists

    Paris, France
    April 24-25, 2023

    36th European Neurology Congress 2023

    Amsterdam, Netherlands
    May 22-23, 2023

    International Congress on Neurology Surgery

    London, UK
    June 23-24, 2023

    3rd Worldwide Forum on Alzheimer and Dementia

    Paris, France
    August 07-08, 2023

    35th World Neuroscience and Neurology Conferences

    Amsterdam, Netherlands
    August 07-08, 2023

    35th World Congress for Neurorehabilitation

    Amsterdam, Netherlands
    September 08-09, 2023

    35th World Conference on Neurology

    London, UK

    Biomarkers in Neuroimaging Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in